Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM43W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,825
Award facts
- Contract value 100% obligated
- $42,825.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,825.34 to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injections on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. The delivery order was issued under the parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
This award reflects AmerisourceBergen's ongoing role as a key pharmaceutical supplier within the Defense Health System. DUPIXENT (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe eosinophilic gastritis. The single-award IDC under which this delivery order was issued enables efficient procurement of specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FM43W?
SPE2DR26FM43W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FM43W worth?
The government has obligated $42,825 on SPE2DR26FM43W.
Is contract SPE2DR26FM43W an order under another contract?
Yes. SPE2DR26FM43W is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM43W competed?
The extent of competition for SPE2DR26FM43W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award